eBook: Best Practices in Streamlining Your NDA/BLA Submission Process

Submitting an NDA or BLA is a complex and risky process. Without early and manageable planning, team alignment and frequent regulatory engagement - the potential for delays and risks in compliance grows.

Discover how a proven phased approach by MMS simplifies the process, building sponsor confidence, reducing risks and accelerating delivery. Key strategies include:

• An actionable NDA/BLA readiness checklist and ongoing best practices (enclosed) to stay on track
• A four-staged approach to submission planning to set achievable milestones and improve forecasting
• Embedding a submission strategy from the beginning to prevent last-minute barriers to timely delivery
• Early identification and management of challenges
• Frequent and early regulator engagement, particularly for new sponsors or rare disease submissions
• Efficient and effective management of submission content